Kissei Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3240600001
JPY
4,585.00
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
88,330.00
75,579.00
67,493.00
65,381.00
69,044.00
63,245.00
72,302.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
88,330.00
75,579.00
67,493.00
65,381.00
69,044.00
63,245.00
72,302.00
Raw Material Cost
47,359.00
41,155.00
37,792.00
36,360.00
38,156.00
29,325.00
27,644.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
21.00
18.00
20.00
23.00
23.00
23.00
23.00
Selling and Distribution Expenses
22,179.00
20,790.00
20,304.00
19,923.00
19,607.00
21,133.00
22,577.00
Other Expenses
1,286.80
945.60
1,037.10
1,034.00
960.30
1,074.40
1,568.80
Total Expenditure (Excl Depreciation)
82,427.00
71,419.00
68,487.00
66,646.00
67,389.00
61,225.00
65,932.00
Operating Profit (PBDIT) excl Other Income
5903
4160
-994
-1265
1655
2020
6370
Other Income
13,064.00
10,143.00
14,777.00
18,373.00
5,347.00
3,599.00
1,168.00
Operating Profit (PBDIT)
23,634.00
18,414.00
17,743.00
20,701.00
10,001.00
8,018.00
9,979.00
Interest
21.00
18.00
20.00
23.00
23.00
23.00
23.00
Exceptional Items
-3,203.00
306.00
65.00
-440.00
646.00
-803.00
-225.00
Gross Profit (PBDT)
40,971.00
34,424.00
29,701.00
29,021.00
30,888.00
33,920.00
44,658.00
Depreciation
4,796.00
4,254.00
4,109.00
3,730.00
3,148.00
2,562.00
2,607.00
Profit Before Tax
15,610.00
14,449.00
13,680.00
16,507.00
7,476.00
4,630.00
7,121.00
Tax
3,634.00
3,159.00
3,046.00
3,475.00
2,098.00
1,741.00
1,586.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
11,961.00
11,161.00
10,529.00
12,922.00
5,285.00
2,817.00
5,481.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
11,961.00
11,161.00
10,529.00
12,922.00
5,285.00
2,817.00
5,481.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
14.00
128.00
105.00
110.00
93.00
71.00
54.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
11,975.00
11,289.00
10,634.00
13,032.00
5,378.00
2,888.00
5,535.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
2,09,004.00
2,20,029.00
1,93,900.00
2,01,386.00
2,19,315.00
1,92,466.00
1,82,263.00
Earnings per share (EPS)
274.2
246.58
228.3
280.19
113.25
60.3
117.33
Diluted Earnings per share
274.2
246.58
228.3
280.19
113.25
60.3
117.33
Operating Profit Margin (Excl OI)
6.54%
5.31%
-1.69%
-2.14%
2.18%
2.94%
8.58%
Gross Profit Margin
23.1%
24.75%
26.36%
30.95%
15.39%
11.37%
13.45%
PAT Margin
13.54%
14.77%
15.6%
19.76%
7.65%
4.45%
7.58%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 16.87% vs 11.98% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is 6.08% vs 6.16% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 27.80% vs 178.86% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 16.67% vs -10.00% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Compare Annual Results Of Kissei Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
88,330.00
47,618.00
40,712.00
85.50%
Other Operating Income
0.00
0.00
0.00
Total Operating income
88,330.00
47,618.00
40,712.00
85.50%
Raw Material Cost
47,359.00
17,617.00
29,742.00
168.83%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
21.00
478.00
-457.00
-95.61%
Selling and Distribution Expenses
22,179.00
28,856.00
-6,677.00
-23.14%
Other Expenses
1,286.80
36.50
1,250.30
3,425.48%
Total Expenditure (Excl Depreciation)
82,427.00
47,316.00
35,111.00
74.21%
Operating Profit (PBDIT) excl Other Income
5,903.00
302.00
5,601.00
1,854.64%
Other Income
13,064.00
989.00
12,075.00
1,220.93%
Operating Profit (PBDIT)
23,634.00
4,889.00
18,745.00
383.41%
Interest
21.00
478.00
-457.00
-95.61%
Exceptional Items
-3,203.00
-1,117.00
-2,086.00
-186.75%
Gross Profit (PBDT)
40,971.00
30,001.00
10,970.00
36.57%
Depreciation
4,796.00
3,598.00
1,198.00
33.30%
Profit Before Tax
15,610.00
-305.00
15,915.00
5,218.03%
Tax
3,634.00
-71.00
3,705.00
5,218.31%
Provisions and contingencies
0
0
0.00
Profit After Tax
11,961.00
-650.00
12,611.00
1,940.15%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
11,961.00
-650.00
12,611.00
1,940.15%
Share in Profit of Associates
0
0
0.00
Minority Interest
14.00
417.00
-403.00
-96.64%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
11,975.00
-233.00
12,208.00
5,239.48%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
2,09,004.00
31,704.00
1,77,300.00
559.24%
Earnings per share (EPS)
274.20
-4.84
279.04
5,765.29%
Diluted Earnings per share
274.20
-4.84
279.04
5,765.29%
Operating Profit Margin (Excl OI)
6.54%
0.63%
0.00
5.91%
Gross Profit Margin
23.10%
6.92%
0.00
16.18%
PAT Margin
13.54%
-1.37%
0.00
14.91%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 8,833.00 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 16.87% vs 11.98% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 1,197.50 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 6.08% vs 6.16% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,057.00 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 27.80% vs 178.86% in Mar 2024

Annual - Interest
Interest 2.10 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 16.67% vs -10.00% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 6.54%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has improved from Mar 2024